Cisco DNA-P-15M-A-1M DNA Advantage On-Premise License | 30M Agg — DNA-P-15M-A-1M

Cisco DNA Advantage on-premise licensing gives enterprise teams a structured way to plan network software coverage without losing control of deployment timing or entitlement scope. The aggregate 30M model supports longer planning horizons, while the 1M designation helps procurement and operations align the license to a defined consumption or coverage requirement. This is the kind of licensing model that matters when the network is already large, the change window is tight, and the cost of ambiguity is high. It supports organizations that need predictable software access for Cisco DNA Advantage capabilities while keeping the license anchored to an on-premise operating model. For buyers, the appeal is precision and governance. You get a Cisco license aligned to enterprise infrastructure planning, with enough structure to support budget review, renewal management, and deployment accountability. That makes it a strong fit for teams that value control over convenience. Ideal For License Cisco DNA Advantage capabilities in an on-premise enterprise environment Align software entitlement to a 30M aggregate planning cycle Support procurement review for a defined 1M coverage requirement Manage network software access across controlled enterprise deployments Why This Product 1 On-premise licensing supports tighter deployment control 2 Aggregate 30M term helps structure long-range planning 3 1M entitlement aligns coverage to a defined requirement 4 Cisco DNA Advantage focus fits enterprise network operations